Cargando…
Role of Radiotherapy in Patients With Relapsed Medulloblastoma
During the last three decades, the management of medulloblastoma (MBL) has made enormous progress with a multidisciplinary approach, incorporating surgery, radiotherapy (RT), and chemotherapy. Despite this improvement, 20%–30% of patients with MBL remain at risk of disease recurrence, with its relap...
Autor principal: | Lim, Do Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Brain Tumor Society; The Korean Society for Neuro-Oncology; The Korean Society for Pediatric Neuro-Oncology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911706/ https://www.ncbi.nlm.nih.gov/pubmed/36762805 http://dx.doi.org/10.14791/btrt.2022.0033 |
Ejemplares similares
-
Relapsed Medulloblastoma in Pre-Irradiated Patients: Current Practice for Diagnostics and Treatment
por: Hill, Rebecca M., et al.
Publicado: (2021) -
Hypercarbia in a Pediatric Patient With Relapsed Medulloblastoma
por: Luangrath, Mitchell A, et al.
Publicado: (2022) -
Bilateral Simultaneous Temporal Relapses of Medulloblastoma
por: Martinez-Moreno, Mauricio, et al.
Publicado: (2018) -
Radiotherapy in Medulloblastoma—Evolution of Treatment, Current Concepts and Future Perspectives
por: Seidel, Clemens, et al.
Publicado: (2021) -
A SHHecret target of relapsed medulloblastoma: Astrocytes
por: Qadeer, Zulekha A., et al.
Publicado: (2021)